Zhang Jing, Zhuang Jing, Yu Ke-Ming
Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Affiliated Shenzhen Eye Hospital of Jinan University, Shenzhen 518040, Guangdong Province, China.
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China.
Int J Ophthalmol. 2018 Nov 18;11(11):1870-1874. doi: 10.18240/ijo.2018.11.21. eCollection 2018.
This study aims to evaluate the clinical results of posterior chamber implantable collamer lens (ICL) implantation in adults with high myopic anisometropic amblyopia. Thirteen patients aged 27.04±7.24y (range 19.2 to 42.5) were studied. ICL implantation was performed in 13 amblyopic eyes. The mean myopic anisometropia was significantly dropped from -10.70±3.02 D preoperatively to +0.09±1.67 D at 1mo postoperatively. The logMAR CDVA at 3d, 1, 3 and mean 9mo postoperatively improved by a mean of 1.69, 2.50, 3.01 and 3.00 lines and gained more than 2 lines accounted for 23.08% (3 eyes), 41.67% (5 eyes), 63.63% (7 eyes) and 55.56% (5 eyes), respectively. The contrast sensitivity of amblyopic eyes was significantly increased after surgery. Four patients partially recovered near stereopsis (400″ to 100″). There was no severe complications were observed. ICL implantation alone can improve vision, contrast sensitivity, and partial restoration of binocular vision in adult patients with high myopic anisometropia.
本研究旨在评估后房型可植入式胶原晶状体（ICL）植入术治疗成人高度近视性屈光参差性弱视的临床效果。研究对象为13例年龄在27.04±7.24岁（范围19.2至42.5岁）的患者。对13只弱视眼进行了ICL植入术。平均近视性屈光参差术前为-10.70±3.02D，术后1个月显著降至+0.09±1.67D。术后3天、1个月、3个月及平均9个月时的logMAR最佳矫正视力（CDVA）平均提高了1.69、2.50、3.01及3.00行，提高超过2行者分别占23.08%（3只眼）、41.67%（5只眼）、63.63%（7只眼）及55.56%（5只眼）。术后弱视眼的对比敏感度显著提高。4例患者部分恢复了近立体视（400″至100″）。未观察到严重并发症。单纯ICL植入术可提高成人高度近视性屈光参差患者的视力、对比敏感度，并部分恢复双眼视功能。
